Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR-58.5%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
-58.5%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 2.56% |
| 2023 | 96.64% |
| 2022 | 60.80% |
| 2021 | -63614.29% |
| 2020 | 133.33% |
| 2019 | 209.09% |
| 2018 | -4130.77% |
| 2017 | 0.00% |